Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation-Reference-Cited by-同舟云学术

Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation

Published:2018-01-04 Issue:1 Volume:131 Page:84-94
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Akhtari Mani¹²,Milgrom Sarah A.¹,Pinnix Chelsea C.¹,Reddy Jay P.¹,Dong Wenli³,Smith Grace L.¹,Mawlawi Osama⁴,Abou Yehia Zeinab¹,Gunther Jillian¹,Osborne Eleanor M.¹,Andraos Therese Y.¹,Wogan Christine F.¹,Rohren Eric⁵,Garg Naveen⁶,Chuang Hubert⁷,Khoury Joseph D.⁸,Oki Yasuhiro⁹,Fanale Michelle⁹,Dabaja Bouthaina S.¹

Affiliation:

1. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;

2. Department of Radiation Oncology, The University of Texas Medical Branch Hospitals, Galveston, TX;

3. Department of Biostatistics and

4. Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX;

5. Department of Radiology, Baylor College of Medicine, Houston, TX; and

6. Department of Diagnostic Radiology,

7. Department of Nuclear Medicine,

8. Department of Hematopathology, and

9. Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Abstract

Publisher's Note: There is a Blood Commentary on this article in this issue.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/131/1/84/1368126/blood773838.pdf

Reference19 articles.

1. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin’s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial;Eich;J Clin Oncol,2010

2. Reduced treatment intensity in patients with early-stage Hodgkin’s lymphoma;Engert;N Engl J Med,2010

3. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

4. Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC/LYSA/FIL H10 trial;André;J Clin Oncol,2017

5. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting;Lister;J Clin Oncol,1989

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hodgkin Lymphoma: Next Questions;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Metabolic tumour area: a novel prognostic indicator based on 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma in the R-CHOP era;BMC Cancer;2024-07-25

3. Quarter-Century PET/CT Transformation of Oncology: Lymphoma;PET Clinics;2024-04

4. Evaluating Outcome Prediction via Baseline, End-of-Treatment, and Delta Radiomics on PET-CT Images of Primary Mediastinal Large B-Cell Lymphoma;Cancers;2024-03-08

5. Prognostic value of baseline and interim [18F]FDG PET metabolic parameters in pediatric Hodgkin’s lymphoma;European Journal of Nuclear Medicine and Molecular Imaging;2024-02-14